{"id":"https://openalex.org/W2591678263","doi":"https://doi.org/10.1016/j.rmed.2017.03.015","title":"Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension\u2122 Delivery Technology in patients with chronic obstructive pulmonary disease","display_name":"Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension\u2122 Delivery Technology in patients with chronic obstructive pulmonary disease","publication_year":2017,"publication_date":"2017-03-12","ids":{"openalex":"https://openalex.org/W2591678263","doi":"https://doi.org/10.1016/j.rmed.2017.03.015","mag":"2591678263","pmid":"https://pubmed.ncbi.nlm.nih.gov/28427541"},"language":"en","primary_location":{"id":"doi:10.1016/j.rmed.2017.03.015","doi":"https://doi.org/10.1016/j.rmed.2017.03.015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2017.03.015","pdf_url":"http://www.resmedjournal.com/article/S0954611117300720/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.resmedjournal.com/article/S0954611117300720/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021493691","display_name":"Nicola Alexander Hanania","orcid":"https://orcid.org/0000-0003-3087-9530","observed_orcids":["https://orcid.org/0000-0003-3087-9530"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicola A. Hanania","raw_affiliation_strings":["Baylor College of Medicine, Houston, TX, USA. Electronic address: hanania@bcm.edu","Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine, Houston, TX, USA. Electronic address: hanania@bcm.edu","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062711392","display_name":"Donald P. Tashkin","orcid":"https://orcid.org/0000-0002-5607-4872","observed_orcids":["https://orcid.org/0000-0002-5607-4872"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald P. Tashkin","raw_affiliation_strings":["David Geffen School of Medicine at UCLA, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"David Geffen School of Medicine at UCLA, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025257736","display_name":"Edward Kerwin","orcid":"https://orcid.org/0000-0002-1697-9036","observed_orcids":["https://orcid.org/0000-0002-1697-9036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward M. Kerwin","raw_affiliation_strings":["Clinical Research Institute of Southern Oregon, Medford, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Institute of Southern Oregon, Medford, OR, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103007231","display_name":"James F. Donohue","orcid":"https://orcid.org/0000-0002-4439-6866","observed_orcids":["https://orcid.org/0000-0002-4439-6866"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James F. Donohue","raw_affiliation_strings":["University of North Carolina School of Medicine, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012974329","display_name":"Michael Denenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Denenberg","raw_affiliation_strings":["Clinical Research of Rock Hill, Rock Hill, SC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research of Rock Hill, Rock Hill, SC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037474136","display_name":"Denis E. O\u2019Donnell","orcid":"https://orcid.org/0000-0001-7593-2433","observed_orcids":["https://orcid.org/0000-0001-7593-2433"]},"institutions":[{"id":"https://openalex.org/I204722609","display_name":"Queen's University","ror":"https://ror.org/02y72wh86","country_code":"CA","type":"education","lineage":["https://openalex.org/I204722609"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Denis E. O'Donnell","raw_affiliation_strings":["Queen's University, Kingston, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen's University, Kingston, ON, Canada","institution_ids":["https://openalex.org/I204722609"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112881658","display_name":"Dean Quinn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dean Quinn","raw_affiliation_strings":["P3 Research Ltd., Newtown, Wellington, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"P3 Research Ltd., Newtown, Wellington, New Zealand","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011502862","display_name":"Shahid S. Siddiqui","orcid":"https://orcid.org/0000-0001-9726-9003","observed_orcids":["https://orcid.org/0000-0001-9726-9003"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shahid Siddiqui","raw_affiliation_strings":["AstraZeneca (Former Employee of Pearl Therapeutics Inc.), Gaithersburg, MD, USA"],"raw_orcid":"https://orcid.org/0000-0001-9726-9003","affiliations":[{"raw_affiliation_string":"AstraZeneca (Former Employee of Pearl Therapeutics Inc.), Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108211117","display_name":"Chad Orevillo","orcid":"https://orcid.org/0009-0003-4220-2508","observed_orcids":["https://orcid.org/0009-0003-4220-2508"]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chad Orevillo","raw_affiliation_strings":["Pearl Therapeutics Inc., Morristown, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics Inc., Morristown, NJ, USA","institution_ids":["https://openalex.org/I4405280598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105700952","display_name":"Andrea L. Maes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Maes","raw_affiliation_strings":["Pearl Therapeutics Inc., Morristown, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics Inc., Morristown, NJ, USA","institution_ids":["https://openalex.org/I4405280598"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077419098","display_name":"Colin Reisner","orcid":"https://orcid.org/0000-0003-1856-9863","observed_orcids":["https://orcid.org/0000-0003-1856-9863"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]},{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colin Reisner","raw_affiliation_strings":["Pearl Therapeutics Inc., Morristown, NJ, USA; AstraZeneca, Morristown, NJ, USA","AstraZeneca, Morristown, NJ, USA","Pearl Therapeutics Inc., Morristown, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics Inc., Morristown, NJ, USA; AstraZeneca, Morristown, NJ, USA","institution_ids":[]},{"raw_affiliation_string":"AstraZeneca, Morristown, NJ, USA","institution_ids":["https://openalex.org/I4210150756"]},{"raw_affiliation_string":"Pearl Therapeutics Inc., Morristown, NJ, USA","institution_ids":["https://openalex.org/I4405280598"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5021493691"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":3630,"currency":"USD","value_usd":3630},"apc_paid":{"value":3630,"currency":"USD","value_usd":3630},"fwci":10.8722,"has_fulltext":true,"cited_by_count":70,"citation_normalized_percentile":{"value":0.98931254,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"126","issue":null,"first_page":"105","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.5313000082969666,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":0.46560001373291016,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metered-dose-inhaler","display_name":"MDI","score":0.9169999957084656},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9589999914169312},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.8650000095367432},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.722000002861023},{"id":"https://openalex.org/keywords/tiotropium","display_name":"tiotropium","score":0.781000018119812},{"id":"https://openalex.org/keywords/fev1","display_name":"FEV1","score":0.7509999871253967},{"id":"https://openalex.org/keywords/rescue-medication-use","display_name":"rescue medication use","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dyspnea","display_name":"dyspnea","score":0.9380000233650208},{"id":"https://openalex.org/keywords/st-george-s-respiratory-questionnaire","display_name":"St George's Respiratory Questionnaire","score":0.8809999823570251},{"id":"https://openalex.org/keywords/anticholinergic-bronchodilators","display_name":"anticholinergic bronchodilators","score":0.6980000138282776},{"id":"https://openalex.org/keywords/long-acting-beta-agonists","display_name":"long-acting beta2-agonists","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8881114721298218},{"id":"https://openalex.org/C2776017024","wikidata":"https://www.wikidata.org/wiki/Q683031","display_name":"Pinnacle","level":4,"score":0.8837889432907104},{"id":"https://openalex.org/C2780667556","wikidata":"https://www.wikidata.org/wiki/Q16897784","display_name":"Metered-dose inhaler","level":4,"score":0.7230232357978821},{"id":"https://openalex.org/C2909086917","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol Fumarate","level":5,"score":0.6874322891235352},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6047849059104919},{"id":"https://openalex.org/C2776780178","wikidata":"https://www.wikidata.org/wiki/Q199804","display_name":"COPD","level":2,"score":0.5813160538673401},{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.5759909749031067},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.4962354302406311},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.4157346189022064},{"id":"https://openalex.org/C75603125","wikidata":"https://www.wikidata.org/wiki/Q1877462","display_name":"Pulmonary function testing","level":2,"score":0.4142459034919739},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3843579888343811},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36664578318595886},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.06546062231063843},{"id":"https://openalex.org/C201645570","wikidata":"https://www.wikidata.org/wiki/Q830637","display_name":"Radiation treatment planning","level":3,"score":0.0},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000069447","descriptor_name":"Tiotropium Bromide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000069447","descriptor_name":"Tiotropium Bromide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004417","descriptor_name":"Dyspnea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005541","descriptor_name":"Forced Expiratory Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006024","descriptor_name":"Glycopyrrolate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012907","descriptor_name":"Smoking","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D036501","descriptor_name":"Metered Dose Inhalers","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D058666","descriptor_name":"Adrenergic beta-2 Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058666","descriptor_name":"Adrenergic beta-2 Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.rmed.2017.03.015","doi":"https://doi.org/10.1016/j.rmed.2017.03.015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2017.03.015","pdf_url":"http://www.resmedjournal.com/article/S0954611117300720/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},{"id":"pmid:28427541","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28427541","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory medicine","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":{"id":"doi:10.1016/j.rmed.2017.03.015","doi":"https://doi.org/10.1016/j.rmed.2017.03.015","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.rmed.2017.03.015","pdf_url":"http://www.resmedjournal.com/article/S0954611117300720/pdf","source":{"id":"https://openalex.org/S71995303","display_name":"Respiratory Medicine","issn_l":"0954-6111","issn":["0954-6111","1532-3064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Respiratory Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2591678263.pdf","grobid_xml":"https://content.openalex.org/works/W2591678263.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W243325842","https://openalex.org/W1901890356","https://openalex.org/W1980016322","https://openalex.org/W1984477495","https://openalex.org/W2003293665","https://openalex.org/W2006528231","https://openalex.org/W2023492022","https://openalex.org/W2026585673","https://openalex.org/W2030987445","https://openalex.org/W2039237831","https://openalex.org/W2048919604","https://openalex.org/W2052977441","https://openalex.org/W2055589748","https://openalex.org/W2056040906","https://openalex.org/W2077722212","https://openalex.org/W2086199047","https://openalex.org/W2089834473","https://openalex.org/W2094324286","https://openalex.org/W2102583457","https://openalex.org/W2107272163","https://openalex.org/W2112433656","https://openalex.org/W2117079401","https://openalex.org/W2123084333","https://openalex.org/W2123850585","https://openalex.org/W2128643475","https://openalex.org/W2133080325","https://openalex.org/W2133986277","https://openalex.org/W2134820467","https://openalex.org/W2137498215","https://openalex.org/W2139192099","https://openalex.org/W2141034778","https://openalex.org/W2141051651","https://openalex.org/W2142449488","https://openalex.org/W2149199480","https://openalex.org/W2155854731","https://openalex.org/W2159837316","https://openalex.org/W2162430901","https://openalex.org/W2171974515","https://openalex.org/W2317895461","https://openalex.org/W2365138737","https://openalex.org/W2478829584","https://openalex.org/W2558903543","https://openalex.org/W2576614024","https://openalex.org/W2977973316","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2558903543","https://openalex.org/W2999792147","https://openalex.org/W2568255753","https://openalex.org/W3083968048","https://openalex.org/W2808568355","https://openalex.org/W2892705619","https://openalex.org/W3028897368","https://openalex.org/W6958808082","https://openalex.org/W2906087097","https://openalex.org/W2508659471"],"abstract_inverted_index":{"Background":[0],"The":[1,92],"long-term":[2,241],"safety":[3,30,143,242],"and":[4,43,46,101,130,172,181,202,226,243],"efficacy":[5,102,259],"of":[6,35,124,245],"a":[7,28],"novel":[8],"Co-Suspension\u2122":[9],"Delivery":[10],"Technology":[11],"glycopyrrolate":[12],"(GP)/formoterol":[13],"fumarate":[14],"(FF)":[15],"18/9.6":[16,248],"\u03bcg":[17,77,249],"fixed-dose":[18],"combination":[19],"metered":[20],"dose":[21],"inhaler":[22],"(GFF":[23],"MDI)":[24],"were":[25,83,103,135,178,211,261],"investigated":[26],"in":[27,48,79,116,149,156,218,227,251,258],"28-week":[29],"extension":[31],"study":[32],"(PINNACLE-3,":[33],"NCT01970878)":[34],"two":[36],"randomized":[37,112],"controlled":[38],"Phase":[39],"III":[40],"trials":[41],"(PINNACLE-1":[42],"-2;":[44],"NCT01854645":[45],"NCT01854658)":[47],"subjects":[49,111,252],"with":[50,64,140,213,253],"moderate-to-very":[51,254],"severe":[52,255],"chronic":[53],"obstructive":[54],"pulmonary":[55],"disease":[56],"(COPD).":[57],"Methods":[58],"Subjects":[59],"completing":[60],"24":[61],"weeks'":[62],"treatment":[63,88,115,138,162],"GFF":[65,165,197,214,246],"MDI,":[66,68,169],"GP":[67,168,200,235],"FF":[69,170],"MDI":[70,166,171,198,201,215,247],"(all":[71],"twice-daily)":[72],"or":[73,81,118],"open-label":[74,173,203],"tiotropium":[75,174,204],"18":[76],"(once-daily)":[78],"PINNACLE-1":[80,117],"-2":[82],"randomly":[84],"selected":[85],"to":[86,113],"continue":[87],"for":[89,95,164,196],"28":[90],"weeks.":[91,107,266],"target":[93],"enrollment":[94],"PINNACLE-3":[96],"was":[97,193],"850":[98],"subjects.":[99],"Safety":[100],"evaluated":[104],"over":[105,175,264],"52":[106,176,265],"Results":[108,238],"Of":[109],"3274":[110],"active":[114],"-2,":[119],"892":[120],"entered":[121],"PINNACLE-3.":[122],"Incidences":[123],"adverse":[125,128,132],"events,":[126],"serious":[127],"events":[129,134],"major":[131],"cardiovascular":[133],"similar":[136],"across":[137],"groups":[139],"no":[141],"unexpected":[142],"findings.":[144],"For":[145],"change":[146],"from":[147],"baseline":[148],"morning":[150],"pre-dose":[151],"trough":[152],"forced":[153],"expiratory":[154],"volume":[155],"1":[157,160],"s":[158],"(FEV":[159],"),":[161],"differences":[163],"versus":[167,199,216,234],"weeks":[177],"57,":[179],"65":[180],"25":[182],"mL,":[183],"respectively":[184],"(p":[185,205],"\u2264":[186,206],"0.0117).":[187],"Average":[188],"daily":[189],"rescue":[190],"medication":[191],"use":[192],"significantly":[194],"reduced":[195],"0.0002).":[207],"Statistically":[208],"significant":[209],"improvements":[210],"observed":[212],"monocomponents":[217],"Self-Administered":[219],"Computerized":[220],"Transition":[221],"Dyspnea":[222],"Index":[223],"focal":[224],"score,":[225],"St":[228],"George's":[229],"Respiratory":[230],"Questionnaire":[231],"total":[232],"score":[233],"MDI.":[236],"Conclusions":[237],"confirmed":[239],"the":[240],"tolerability":[244],"twice-daily":[250],"COPD.":[256],"Improvements":[257],"endpoints":[260],"also":[262],"sustained":[263]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2017-03-16T00:00:00"}